Patents and exclusivity rights for Zelboraf (vemurafenib) prevent any generic versions of the drug from being manufactured at this time. After the first patent expires in October 2026.
Zelboraf (vemurafenib) is made by Daiichi Sankyo, Inc., for Genentech USA, Inc.
2 Hilton Court
Parsippany, NJ 07054
Phone: 973 359 2600
1 DNA Way
South San Francisco, CA 94080-4990
Phone: (650) 225-1000
- Vemurafenib Information for Consumers
- Vemurafenib Information for Healthcare Professionals (includes dosage details)
- Side Effects of Vemurafenib (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 30 Jun 2012 • 1 answer
Posted 16 Aug 2012 • 2 answers
Posted 15 Apr 2013 • 1 answer
Posted 18 Jul 2013 • 2 answers